Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease
Evaluation of Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease in Assiut University Hospitals
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Detection of Inflammatory Bowel Disease activity by Using new measure : Neutrophil to lymphocyte ratio
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2020
CompletedFirst Posted
Study publicly available on registry
September 22, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedSeptember 22, 2020
September 1, 2020
1 year
September 16, 2020
September 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neutrophil to lymphocyte ratio in IBD
Determination of the prognostic value of N/L ratio in patients with IBD as a non invasive measure of disease acitivity
baseline
Interventions
neutrophil to lymphocyte ratio
Eligibility Criteria
Patients diagnosed IBD by endoscopy, clinical , biochemical correlation and histopathological biopsy
You may qualify if:
- patients with inflammatory bowel disease, diagnosed by endoscopy, clinical , biochemical correlation and histopathological biopsy
You may not qualify if:
- patients have :
- Appendicitis
- sigmoid diverticular disease
- Infectious colitis
- patients known to have cancer colon
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Argeny S, Stift A, Bergmann M, Mittlbock M, Maschke S, Yang Y, Chitsabesan P, Riss S. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn's disease. Wien Klin Wochenschr. 2018 Jun;130(11-12):398-403. doi: 10.1007/s00508-018-1322-3. Epub 2018 Feb 12.
PMID: 29435759BACKGROUNDCelikbilek M, Dogan S, Ozbakir O, Zararsiz G, Kucuk H, Gursoy S, Yurci A, Guven K, Yucesoy M. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal. 2013 Jan;27(1):72-6. doi: 10.1002/jcla.21564. Epub 2013 Jan 4.
PMID: 23292894BACKGROUNDGao SQ, Huang LD, Dai RJ, Chen DD, Hu WJ, Shan YF. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14779-85. eCollection 2015.
PMID: 26823804BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Evaluation of neutrophil-to-lymphocyte ratio in inflammatory bowel disease in assuit university hospitals
Study Record Dates
First Submitted
September 16, 2020
First Posted
September 22, 2020
Study Start
December 1, 2020
Primary Completion
December 1, 2021
Study Completion
January 1, 2022
Last Updated
September 22, 2020
Record last verified: 2020-09